Financhill
Sell
41

PSGTY Quote, Financials, Valuation and Earnings

Last price:
$3.26
Seasonality move :
0.05%
Day range:
$3.26 - $3.26
52-week range:
$2.38 - $3.70
Dividend yield:
3.62%
P/E ratio:
157.49x
P/S ratio:
0.51x
P/B ratio:
0.42x
Volume:
--
Avg. volume:
21
1-year change:
-17.92%
Market cap:
$1.1B
Revenue:
$2.3B
EPS (TTM):
$0.02

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Downside
    No price target exists because of limited analyst coverage.
  • Price Target Upside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, PT Semen Indonesia (Persero) Tbk has -- downside to fair value with a price target of -- per share.

PSGTY vs. S&P 500

  • Over the past 5 trading days, PT Semen Indonesia (Persero) Tbk has underperformed the S&P 500 by -3.94% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • PT Semen Indonesia (Persero) Tbk does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • PT Semen Indonesia (Persero) Tbk revenues have been falling on a year-over-year basis for 8 quarters in a row. In the most recent quarter PT Semen Indonesia (Persero) Tbk reported revenues of $587.7M.

Earnings Growth

  • PT Semen Indonesia (Persero) Tbk earnings have been falling on a year-over-year basis for 12 quarters in a row. In the most recent quarter PT Semen Indonesia (Persero) Tbk reported earnings per share of $0.01.
Enterprise value:
1.8B
EV / Invested capital:
0.51x
Price / LTM sales:
0.51x
EV / EBIT:
18.99x
EV / Revenue:
0.83x
PEG ratio (5yr expected):
--
EV / Free cash flow:
11.30x
Price / Operating cash flow:
6.93x
Enterprise value / EBITDA:
6.10x
Gross Profit (TTM):
$384.5M
Return On Assets:
0.25%
Net Income Margin (TTM):
0.54%
Return On Equity:
0.39%
Return On Invested Capital:
0.32%
Operating Margin:
5.02%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $2.5B $2.4B $2.2B $626.2M $587.7M
Gross Profit $660.6M $513.6M $384.5M $127M $102.6M
Operating Income $304.4M $178.5M $94.3M $40.2M $29.5M
EBITDA $531.9M $386.8M $293.7M $91.7M $78.7M
Diluted EPS $0.47 $0.22 $0.02 $0.04 $0.01
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $1.1B $904.5M $1.2B $1.2B $1B
Total Assets $5.4B $4.9B $5.3B $5.2B $4.6B
Current Liabilities $981.6M $798.6M $973.1M $896.1M $914.6M
Total Liabilities $2.6B $2.2B $2.2B $2B $1.7B
Total Equity $2.7B $2.7B $3.1B $3.2B $2.9B
Total Debt $1.4B $912M $1B $695.6M $541.9M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $404.1M $294.7M $228.2M $85.7M $37.7M
Cash From Investing -$110.5M -$109M -$69.8M -$21.5M -$15.8M
Cash From Financing -$92M -$241.8M -$226.1M -$19.8M -$30.8M
Free Cash Flow $290.8M $186.3M $158.6M $64.3M $21.9M
PSGTY
Sector
Market Cap
$1.1B
$21M
Price % of 52-Week High
88.11%
70%
Dividend Yield
3.62%
0%
Shareholder Yield
7.22%
-2.62%
1-Year Price Total Return
-17.92%
10.28%
Beta (5-Year)
0.257
0.621
Dividend yield:
3.62%
Annualized payout:
$0.10
Payout ratio:
-204.13%
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $3.36
200-day SMA
Buy
Level $3.06
Bollinger Bands (100)
Buy
Level 2.96 - 3.22
Chaikin Money Flow
Sell
Level --
20-day SMA
Buy
Level $3.24
Relative Strength Index (RSI14)
Buy
Level 53.88
ADX Line
Neutral
Level
Williams %R
Neutral
Level -55.1724
50-day SMA
Buy
Level $3.17
MACD (12, 26)
Buy
Level 0.46
25-day Aroon Oscillator
Buy
Level 64
On Balance Volume
Neutral
Level --

Financial Scores

Sell
Altman Z-Score (Annual)
Level (1.6995)
Buy
CA Score (Annual)
Level (0.061)
Buy
Beneish M-Score (Annual)
Level (-2.8163)
Sell
Momentum Score
Level (2)
Buy
Ohlson Score
Level (0.2441)
Buy
Piotroski F Score (Annual)
Level (6)
Sell
Quality Ratio Score
Level (2)
Buy
Fundamental Score
Level (7)

Revenue Forecast

Earnings per Share Forecast

Company Profile

PT Semen Indonesia (Persero) Tbk engages in the production and distribution of cement. It operates through the following segments: Cement Production and Non-Cement Production. The Cement Production segments produces and markets cement products. The Non-Cement Production segment includes limestone and clay mining, cement bag manufacturing, industrial real estate, precast and readymix concrete, IT services, logistics, and trading. The company was founded on March 25, 1953 and is headquartered in Jakarta Selatan, Indonesia.

Stock Forecast FAQ

In the current month, PSGTY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The PSGTY average analyst price target in the past 3 months is --.

  • Where Will PT Semen Indonesia (Persero) Tbk Stock Be In 1 Year?

    According to analysts, the consensus estimate is that PT Semen Indonesia (Persero) Tbk share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About PT Semen Indonesia (Persero) Tbk?

    Analysts are divided on their view about PT Semen Indonesia (Persero) Tbk share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that PT Semen Indonesia (Persero) Tbk is a Sell and believe this share price will rise from its current level to --.

  • What Is PT Semen Indonesia (Persero) Tbk's Price Target?

    The price target for PT Semen Indonesia (Persero) Tbk over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is PSGTY A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for PT Semen Indonesia (Persero) Tbk is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of PSGTY?

    You can purchase shares of PT Semen Indonesia (Persero) Tbk via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase PT Semen Indonesia (Persero) Tbk shares.

  • What Is The PT Semen Indonesia (Persero) Tbk Share Price Today?

    PT Semen Indonesia (Persero) Tbk was last trading at $3.26 per share. This represents the most recent stock quote for PT Semen Indonesia (Persero) Tbk. Yesterday, PT Semen Indonesia (Persero) Tbk closed at $3.26 per share.

  • How To Buy PT Semen Indonesia (Persero) Tbk Stock Online?

    In order to purchase PT Semen Indonesia (Persero) Tbk stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Bloom Energy The Best Stock to Buy Now?
Is Bloom Energy The Best Stock to Buy Now?

Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…

Is Berkshire Hathaway Stock Undervalued?
Is Berkshire Hathaway Stock Undervalued?

Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…

Is Oracle Stock Undervalued?
Is Oracle Stock Undervalued?

Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…

Stock Ideas

Sell
49
Is NVDA Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 59x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
55
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 38x

Alerts

Sell
35
SMX alert for Dec 19

SMX (Security Matters) Plc [SMX] is up 11.91% over the past day.

Sell
36
INSP alert for Dec 19

Inspire Medical Systems, Inc. [INSP] is up 1.39% over the past day.

Sell
40
INSM alert for Dec 19

Insmed, Inc. [INSM] is up 4.79% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock